ASTRO recommends that physicians avoid routinely adding adjuvant whole brain radiation therapy (WBRT) to stereotactic radiosurgery (SRS) for treating limited brain metastases.

The use of SRS alone, compared with SRS combined with WBRT, resulted in less cognitive decline three months after treatment in brain metastases patients.